This inventor holds 1 USPTO granted patent. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dipak Gordhan and His Pharmaceutical Patent
Introduction
Dipak Gordhan is an inventor associated with Nottingham, Great Britain. His patent work concerns pharmaceutical compositions involving pralsetinib, a selective RET inhibitor. The available information identifies 1 patent associated with him.
Latest Patents
“Pralsetinib Pharmaceutical Compositions” describes an amorphous solid dispersion containing pralsetinib, or a pharmaceutically acceptable salt of it, together with a hydrophilic polymer and an effervescent couple. The disclosure also covers crystalline forms of pralsetinib and pralsetinib hydrochloride salt, pharmaceutical compositions containing those forms, and methods for using the compositions to treat various disorders.
Career Highlights
Gordhan is associated with Rigel Pharmaceuticals, Incorporated. His identified patent reflects work on pharmaceutical formulations and crystalline forms intended for therapeutic use.
Collaborations
The listed coworkers associated with Gordhan include Joshua Waetzig and Shellie Rigby-Singleton.
Conclusion
Dipak Gordhan’s identified patent focuses on pralsetinib formulations and crystalline forms, highlighting his contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
